Overall, our results are in accordance with previous studies, which indicate that the Survivin cytoplasmic expression is correlated with increased tumor aggressiveness and a lower positive response to radiotherapy treatment in OSCC patients [47,48,49,50]. This evidence concerns the gene BIRC5 and neoplasm.